Brief: ChromoGenics Q3 Oper Loss Widens To SEK 12.8 Mln

ChromoGenics AB

04/11/2022 07:37

Nov 4 (Reuters) - ChromoGenics AB  CHRO.ST :
    * INTERIM REPORT JANUARY - SEPTEMBER 2022
    * NET SALES FOR Q3 2022 AMOUNTED TO SEK 3.5 (7.7) MILLION
    * OPERATING LOSS FOR Q3 2022 AMOUNTED TO SEK -12.8 (-6.3)
    * COMPANY'S OPERATING PROFIT WAS IMPACTED NEGATIVELY BY
COSTS
RELATED TO GULLHAUGS TORG 5 PROJECT IN OSLO

Source text for Eikon:  ID:nWkrG8nPm 
Further company coverage:  CHRO.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))